APP and Alzheimer disease: APP/PS1 transgenic mice, a mouse model commonly used in AD research, harbor appearance of A‐beta plaques starting at 3 months old of age, exhibiting cognitive deficits at 7 months old of age.35, 36, 37, 38, 39, 40, 41